US poised to negotiate drug prices despite fierce pharma lobbying
Por um escritor misterioso
Descrição
Makers of blockbuster drugs including Eli Lilly, AbbVie and AstraZeneca face new curbs
Trump's Claim Drug Companies Are Negotiating Disputed by Lobby
The New War on (Overpriced) Drugs
US poised to negotiate drug prices despite fierce pharma lobbying
The top 15 pharma companies by 2017 revenue
Biden Can Reduce Prescription Drug Prices Without Congress, Warren
Pharma lobby furious over wildly popular effort to curb drug
Pharma Lobby Furious Over Wildly Popular Effort to Curb Drug Prices
Merck and Regeneron Can Thrive Despite Drug Price Pressures for
Most Americans Support Medicare Negotiation for Drug Prices
/s3.amazonaws.com/arc-authors/reuters/0b82a826-fb3f-4043-b864-a941ebaf669d.jpg)
U.S. move to negotiate drug prices a rare defeat for Big Pharma
Pharma groups lose £30bn of value on heartburn drug lawsuit worries
The solutions to America's drug cost dilemma (and why they won't
Biden Targets Popular J&J, Bristol Drugs for Medicare Price Cuts
Drug Price Negotiation Doesn't Mean the Government Will Restrict
Medicare price negotiation: Putnam's round one picks - Putnam
de
por adulto (o preço varia de acordo com o tamanho do grupo)
